Our Science

Our team of scientists works tirelessly to discover first-in-class and-best-in-class therapeutics that target a variety of cancer targets with covalent small molecules. We use state-of-the-art technology and cutting-edge research techniques to develop cancer therapeutics that have the potential to change lives.

 Our unique CovAI™ Platform: Integrating the latest advances in Machine Learning, Artificial Intelligence, structural biology, and physics-based simulations to model the full spectrum of protein dynamics and design first-in-class and best-in-class covalent drugs for cancer.

We have an ambitious, strong, creative, and diverse team of experienced scientists and entrepreneurs.